Shoppers have hailed a skincare gel as a ‘miracle product’ after it cleared up their breakouts. The Dr Sam Bunting's Flawless Neutralising Gel is said to be a‘game changer’, having earned ...

Cadillac has finally received its official approval to join the 2026 Formula 1 grid, ending a year-long drama that started when General Motors and Andretti Global's application was initially ...

Another pause in interest-rate cuts is seen at the March meeting, but central bankers are in a tricky position. We sell different types of products and services to both investment professionals ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU ... of the European Medicines Agency (EMA) based its positive opinion on ...

Beauty enthusiasts are raving about a 'must-have' facial mask. The doctor-approved Anti-Blemish and Scar Repair Silver Mask by 47 Skin, which starts at £21.60 for those who subscribe, has ...

A durvalumab (Imfinzi)-based perioperative regimen has been recommended by the EMA Committee for the treatment of adults ... in combination with chemotherapy has been recommended for approval in the ...

Astrazeneca Pharma India added 2.08% to Rs 6846.10 after the company has received permission from the Central Drugs Standard Control Organisation (CDSCO) to import for sale and distribution of ...

AbbVie announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of upadacitinib ... deliver innovative ...

MediWound's first drug, NexoBrid®, is an FDA- and EMA-approved orphan biologic for eschar removal in deep partial-thickness and/or full-thickness thermal burns, significantly reducing the need for ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended three novel medicines for approval at its February 2025 meeting. The European Commission is expected to announce a ...

If approved, VYJUVEK will be marketed in Europe as a simple, effective therapy for patients from birth. The European Commission's final decision on VYJUVEK is anticipated in the second quarter of ...

Therefore, this positive CHMP opinion marks a crucial milestone toward introducing a more robust preventative solution against ... to regulatory approval of product candidates and review of ...